News - 25 Feb 2010
More should be done across Europe to ensure that people with rare forms of cancer are not denied access to the best possible treatment, say the organizers of a major European cancer conference to be...
News - 3 Nov 2016
Researchers in the social sciences have been searching for a holy grail: an accurate way to predict who is likely to engage in problematic behavior, like using drugs.
News - 4 May 2016
Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its...
News - 12 Jun 2014
Traumatic brain injuries from sports, recreational activities, falls or car accidents are the leading cause of death and disability in children and adolescents. While previously it was believed that...
News - 27 Oct 2010
The American Dental Association (ADA) said today that it welcomes an organization of the stature of the W.K. Kellogg Foundation to join the fight to improve the nation's oral health.
News - 26 Feb 2013
The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed...
News - 29 Jun 2011
Threshold Pharmaceuticals, Inc., today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal cell carcinoma...
News - 22 Mar 2018
Older adults often complain about forgetting, but Penn State psychologists suggest that another problem may be misremembering.
News - 29 Jul 2011
A new study in the Journal of Dental Research finds bone fluoride levels are not associated with osteosarcoma, a rare bone cancer more prevalent in males.
News - 9 Mar 2010
New breakthrough treatments for the most common cancers could soon come from cutting-edge research into some of the world's rarest tumors.